1
/
of
2
LII LAB
Estimated delivery by 3 months.
PICOSITO 30s ~Metabolic Blend for PCOS
Picosito is a clinically backed blend designed to improve insulin resistance, regulate the menstrual cycle, and support fertility.
PICOSITO combines:
- The gold-standard inositol ratio for optimal efficacy
- Clinically supported nutrients for hormonal and metabolic balance
- A clean, purposeful formulation with no unnecessary additives
30 sachets/box: 1 month supply
Special 50% offer for pre-order customers
Quantity
Couldn't load pickup availability
Share
![[PRE-ORDER with Special Promo] Picosito](http://lii-lab.com/cdn/shop/files/Untitled_design_79.png?v=1771032979&width=1445)
Collapsible content
INGREDIENTS
Inositol 2255mg
- Improve insulin resistance
- Weight management
- support fertility
- DOWNREGULATES androgen
VITAMIN D 1000IU
- Hormonal Balance & Ovulation
- Reduced Symptoms
- Metabolic Support
- Anti-Inflammatory Action
Inulin (PREBIOTIC) 1600mg
- Regulate gut dysbiosis
- Maintain a healthy glucose level
- Clean INGREDIENTS as the formula base
Folic Acid 400mcg
- support fertility
- Prevent neural tube defects
USAGE & DIRECTION
- Can be consumed directly from the sachet
- Can mix with 150ml of warm water
Recommended to be taken once daily. DON’T MIX WITH HOT WATER.
We recommend taking PICOSITO for 3 to 6 months for optimal results.
CLINICAL STUDIES
-
Read More
The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial
-
Read More
The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review
-
Read More
Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
-
Read More
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
-
Read More
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
-
Read More
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
-
Read More
The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients
-
Read More
The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
-
Read More
Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports
Customers are saying
5.00 ★ (21)
Verified